Taymeyah Al‐Toubah

1.4k total citations · 1 hit paper
50 papers, 941 citations indexed

About

Taymeyah Al‐Toubah is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Taymeyah Al‐Toubah has authored 50 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Epidemiology, 40 papers in Oncology and 29 papers in Neurology. Recurrent topics in Taymeyah Al‐Toubah's work include Neuroendocrine Tumor Research Advances (42 papers), Lung Cancer Research Studies (35 papers) and Neuroblastoma Research and Treatments (29 papers). Taymeyah Al‐Toubah is often cited by papers focused on Neuroendocrine Tumor Research Advances (42 papers), Lung Cancer Research Studies (35 papers) and Neuroblastoma Research and Treatments (29 papers). Taymeyah Al‐Toubah collaborates with scholars based in United States, Italy and Brazil. Taymeyah Al‐Toubah's co-authors include Jonathan Strosberg, Ghassan El‐Haddad, Brian Morse, Richard D. Kim, Michael J. Schell, Satya Das, Amit Mahipal, Baek‐hui Kim, Dae Won Kim and Vincent Chung and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and CHEST Journal.

In The Last Decade

Taymeyah Al‐Toubah

48 papers receiving 939 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer

2020 306 citations Richard D. Kim, Taymeyah Al‐Toubah et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Taymeyah Al‐Toubah United States	13	769	500	354	328	142	50	941
Alessio Pellegrinelli Italy	14	364 0.5×	284 0.6×	188 0.5×	79 0.2×	93 0.7×	23	519
Susanne M. Hooshmand United States	9	711 0.9×	450 0.9×	314 0.9×	78 0.2×	142 1.0×	12	876
Bradley A. Krasnick United States	17	500 0.7×	261 0.5×	143 0.4×	145 0.4×	150 1.1×	46	733
Nitya Raj United States	15	610 0.8×	563 1.1×	403 1.1×	173 0.5×	53 0.4×	63	843
Pablo Gajate Spain	15	329 0.4×	154 0.3×	127 0.4×	140 0.4×	102 0.7×	51	601
Daishu Miura Japan	14	267 0.3×	135 0.3×	89 0.3×	159 0.5×	89 0.6×	38	592
P. J. Loehrer United States	9	227 0.3×	136 0.3×	292 0.8×	191 0.6×	93 0.7×	18	603
Timothy F. Kozelsky United States	11	352 0.5×	178 0.4×	86 0.2×	69 0.2×	388 2.7×	17	718
Jima Lv China	18	424 0.6×	192 0.4×	75 0.2×	238 0.7×	667 4.7×	49	951
Natalyn Hawk United States	9	432 0.6×	164 0.3×	55 0.2×	91 0.3×	175 1.2×	25	573

Countries citing papers authored by Taymeyah Al‐Toubah

Since Specialization

Citations

This map shows the geographic impact of Taymeyah Al‐Toubah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taymeyah Al‐Toubah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taymeyah Al‐Toubah more than expected).

Fields of papers citing papers by Taymeyah Al‐Toubah

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taymeyah Al‐Toubah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taymeyah Al‐Toubah. The network helps show where Taymeyah Al‐Toubah may publish in the future.

Co-authorship network of co-authors of Taymeyah Al‐Toubah

This figure shows the co-authorship network connecting the top 25 collaborators of Taymeyah Al‐Toubah. A scholar is included among the top collaborators of Taymeyah Al‐Toubah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taymeyah Al‐Toubah. Taymeyah Al‐Toubah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al‐Toubah, Taymeyah, et al.. (2025). Somatostatin Receptor Expression of Gastroenteropancreatic Neuroendocrine Tumors: A Comprehensive Analysis in the Era of Somatostatin Receptor PET Imaging. Cancers. 17(12). 1937–1937. 1 indexed citations

Strosberg, Jonathan, Rachel P. Riechelmann, Jorge Hernando, et al.. (2025). Efficacy of immune checkpoint inhibitors in patients with advanced pancreatic NETs displaying high TMB and MMR alterations following treatment with alkylating agents.. Journal of Clinical Oncology. 43(4_suppl). 662–662. 2 indexed citations

Al‐Toubah, Taymeyah, et al.. (2024). Phase II study of pembrolizumab and lenvatinib in advanced well-differentiated neuroendocrine tumors. ESMO Open. 9(4). 102386–102386. 6 indexed citations

Strosberg, Jonathan, et al.. (2024). Safety and Efficacy of Peptide Receptor Radionuclide Therapy (PRRT) Following Bland Embolization for Metastatic Neuroendocrine Tumors. Cancers. 16(15). 2703–2703. 1 indexed citations

Al‐Toubah, Taymeyah, et al.. (2024). Do Appendiceal Neuroendocrine Tumors Metastasize Post Appendectomy or Right Hemicolectomy?. Journal of the National Comprehensive Cancer Network. 23(1). 1 indexed citations

Barros, Milton, Jonathan Strosberg, Taymeyah Al‐Toubah, et al.. (2023). HORMONET: a phase II trial of tamoxifen for estrogen/progesterone receptor-positive neuroendocrine tumors. Therapeutic Advances in Medical Oncology. 15. 2630777–2630777. 4 indexed citations

Al‐Toubah, Taymeyah, et al.. (2023). Somatostatin Receptor Expression in Lung Neuroendocrine Tumors: An Analysis of DOTATATE PET Scans. Journal of Nuclear Medicine. 64(12). 1895–1898. 8 indexed citations

Al‐Toubah, Taymeyah, et al.. (2023). ACTH‐secreting pancreatic neuroendocrine neoplasms: A case‐series. Journal of Neuroendocrinology. 35(10). e13336–e13336. 2 indexed citations

Al‐Toubah, Taymeyah, Eleonora Pellè, & Jonathan Strosberg. (2023). Risk of Myelodysplastic Syndrome/Acute Leukemia with Sequential Capecitabine/Temozolomide and 177Lu-Dotatate. Endocrine Abstracts.

10.

Al‐Toubah, Taymeyah, Brian Morse, & Jonathan Strosberg. (2022). Efficacy of Capecitabine and Temozolomide in Small Bowel (Midgut) Neuroendocrine Tumors. Current Oncology. 29(2). 510–515. 9 indexed citations

11.

Pellè, Eleonora, Taymeyah Al‐Toubah, Brian Morse, & Jonathan Strosberg. (2022). Belzutifan in a Patient With VHL-Associated Metastatic Pancreatic Neuroendocrine Tumor.. PubMed. 20(12). 1285–1287. 7 indexed citations

12.

Powers, Benjamin D., et al.. (2022). A natural history of gastroenteropancreatic neuroendocrine tumors evaluated at a tertiary cancer center: An observational study of 2,067 cases.. Journal of Clinical Oncology. 40(4_suppl). 508–508. 1 indexed citations

13.

Das, Satya, Taymeyah Al‐Toubah, & Jonathan Strosberg. (2021). Chemotherapy in Neuroendocrine Tumors. Cancers. 13(19). 4872–4872. 20 indexed citations

14.

Pellè, Eleonora, Taymeyah Al‐Toubah, Brian Morse, Ghassan El‐Haddad, & Jonathan Strosberg. (2021). Desmoplastic mesenteric lesions do not respond radiographically to peptide receptor radionuclide therapy. Journal of Neuroendocrinology. 33(2). e12936–e12936. 4 indexed citations

15.

Eng, Cathy, Emerson Y. Chen, Jane E. Rogers, et al.. (2021). Moving Beyond the Momentum: Innovative Approaches to Clinical Trial Implementation. JCO Oncology Practice. 17(10). 607–614. 6 indexed citations

16.

Al‐Toubah, Taymeyah, et al.. (2021). Comparison of Nausea and Vomiting Associated With Amino Acid Formulations Coinfused With Peptide Receptor Radionuclide Therapy. Pancreas. 50(4). 513–515. 7 indexed citations

17.

Al‐Toubah, Taymeyah, Simona Grozinsky‐Glasberg, & Jonathan Strosberg. (2021). An Update on the Management of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH). Current Treatment Options in Oncology. 22(4). 28–28. 3 indexed citations

18.

Al‐Toubah, Taymeyah, Jonathan Strosberg, Þorvarður R. Hálfdánarson, et al.. (2020). Somatostatin Analogs Improve Respiratory Symptoms in Patients With Diffuse Idiopathic Neuroendocrine Cell Hyperplasia. CHEST Journal. 158(1). 401–405. 19 indexed citations

19.

Tan, Elaine, Biwei Cao, Jongphil Kim, et al.. (2020). Phase 2 study of copanlisib in combination with gemcitabine and cisplatin in advanced biliary tract cancers. Cancer. 127(8). 1293–1300. 23 indexed citations

20.

Al‐Toubah, Taymeyah & Jonathan Strosberg. (2018). Peptide Receptor Radiotherapy Comes of Age. Endocrinology and Metabolism Clinics of North America. 47(3). 615–625. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact